Greg J. Riely

<i>HER2</i> Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in <i>EGFR</i> -Mutant Lung Cancers That Lack the Second-Site <i>EGFR</i> T790M Mutation

Ken Takezawa, Valentina Pirazzoli, Maria E. Arcila et al. · Cancer Discovery · 2012 · 720 citations · Full text

An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer

Luciano G. Martelotto, Timour Baslan, Alberto Vides et al. · Nature Medicine · 2017 · 173 citations · Full text

Systems Biology, Medicine, Treatment Resistance +9

Nomogram to predict the presence of<i>EGFR</i>activating mutation in lung adenocarcinoma

Nicolas Girard, Camelia S. Sima, D. M. Jackman et al. · European Respiratory Journal · 2011 · 112 citations · Full text

Phase II Trial of Dasatinib for Patients with Acquired Resistance to Treatment with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Erlotinib or Gefitinib

Melissa L. Johnson, Greg J. Riely, Naiyer A. Rizvi et al. · Journal of Thoracic Oncology · 2011 · 91 citations · Full text

Oncology, Phase Ii Trial, Acquired Resistance +9

Clinical Experience of Cerebrospinal Fluid–Based Liquid Biopsy Demonstrates Superiority of Cell-Free DNA over Cell Pellet Genomic DNA for Molecular Profiling

Tejus Bale, Soo‐Ryum Yang, James P. Solomon et al. · Journal of Molecular Diagnostics · 2021 · 62 citations · Full text

Dna Sequencing, Engineering, Biomedical Diagnostics +13